The Biden administration has issued a legal challenge to invalidate the controversial Texas law that bans abortions after six weeks of pregnancy claiming that it will strip residents of their constitutional rights.
The vendor has agreed to pay nearly $18.3 million to settle allegations that it violated the False Claims Act by offering illegal kickbacks to boost EHR sales. The company denies any wrongdoing and said it agreed to settle to "put the matter behind us."
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Google announced it had closed its planned acquisition of Fitbit on Thursday, even thought the deal is still being investigated by the U.S. Department of Justice.
The charges, filed in Philadelphia federal court, allege that Teva conspired with four other generic drug companies to fix prices, rig bids and allocate customers. Teva - which the Justice Department and New York's state government also sued this month for unrelated allegations - said it rejected the allegations.
The Department of Justice sued Omnicare for allegedly dispensing drugs without valid prescriptions.
The U.S. Department of Justice was investigating Practice Fusion over allegations it violated HIPAA and anti-kickback laws and wrongfully obtained certification for its software from the HHS.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The DOJ claims that IBM subsidiary Cúram Software misrepresented its ability to meet specified technical requirements in its contract to develop Maryland's health insurance exchange website and IT platform.
Last week, the company announced a $225 million settlement with the Department of Justice for civil and criminal investigations into illegal promotion of the cancer pain drug Subsys.
The deal struck Thursday follows similar settlements between the Department of Justice and three other drugmakers. The department alleged that the companies started copay-assistance funds that violated anti-kickback laws.
Sutter Health was allegedly involved in a practice called upcoding, which refers to the submission of incorrect or exaggerated information about the health status of a beneficiary in order to receive a higher payout from CMS.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Regulatory approval for the purchase is predicated on Aetna's previously announced plans to sell off its Medicare Part D business to WellCare Health.